Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy

Lycium barbarum polysaccharide (LBP) as one of the main bioactive constituents of the fruit of Lycium barbarum L. (LBL.) has many pharmacological activities, but its antihyperglycemic activity is not fully understood yet. This study investigated the hypoglycemic and renal protective effects of LBP o...

Full description

Saved in:
Bibliographic Details
Main Authors: Fengqi Wan, Fulin Ma, Jiaxin Wu, Xinyu Qiao, Minxue Chen, Wenjian Li, Liang Ma
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/7847135
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547166722195456
author Fengqi Wan
Fulin Ma
Jiaxin Wu
Xinyu Qiao
Minxue Chen
Wenjian Li
Liang Ma
author_facet Fengqi Wan
Fulin Ma
Jiaxin Wu
Xinyu Qiao
Minxue Chen
Wenjian Li
Liang Ma
author_sort Fengqi Wan
collection DOAJ
description Lycium barbarum polysaccharide (LBP) as one of the main bioactive constituents of the fruit of Lycium barbarum L. (LBL.) has many pharmacological activities, but its antihyperglycemic activity is not fully understood yet. This study investigated the hypoglycemic and renal protective effects of LBP on high-fat diet/streptozotocin- (HFD/STZ-) induced diabetic nephropathy (DN) in mice. Blood glucose was assessed before and after 8-week administration of LBP, and the homeostasis model assessment-insulin resistance (HOMA-IR) index was calculated for evaluating the antidiabetic effect of LBP. Additionally, serum creatinine (sCr), blood urea nitrogen (BUN), and urine microalbumin were tested to evaluate the renal function. HE and PAS stainings were performed to evaluate the morphology and injury of the kidney. The results showed that LBP significantly reduces the glucose level and ameliorates the insulin resistance of diabetic mice. Importantly, LBP improves renal function by lowering the levels of sCr, BUN, and microalbumin in diabetic mice and relieves the injury in the renal glomeruli and tubules of the DN mice. Furthermore, LBP attenuates renal inflammation as evidenced by downregulating the mRNA levels of TNFα, IL1 β, IL6, and SAA3 in the renal cortex, as well as reducing the elevated circulating level and protein depositions of SAA3 in the kidney. In addition, our western blot results showed that NF-κB p65 nuclear translocation and the degradation of inhibitory κB-α (IκBα) occurred during the progress of inflammation, and such activated signaling was restrained by LBP. In conclusion, our findings suggest that LBP is a potential antidiabetic agent, which ameliorates the inflammation in DN through inhibiting NF-κB activation.
format Article
id doaj-art-9c392075187c4fff96e012fb6c12e59b
institution Kabale University
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-9c392075187c4fff96e012fb6c12e59b2025-02-03T06:45:55ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/7847135Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic NephropathyFengqi Wan0Fulin Ma1Jiaxin Wu2Xinyu Qiao3Minxue Chen4Wenjian Li5Liang Ma6Institute of Modern PhysicsCuiying Biomedical Research CenterSchool of PharmacyCuiying Biomedical Research CenterCuiying Biomedical Research CenterInstitute of Modern PhysicsInstitute of Modern PhysicsLycium barbarum polysaccharide (LBP) as one of the main bioactive constituents of the fruit of Lycium barbarum L. (LBL.) has many pharmacological activities, but its antihyperglycemic activity is not fully understood yet. This study investigated the hypoglycemic and renal protective effects of LBP on high-fat diet/streptozotocin- (HFD/STZ-) induced diabetic nephropathy (DN) in mice. Blood glucose was assessed before and after 8-week administration of LBP, and the homeostasis model assessment-insulin resistance (HOMA-IR) index was calculated for evaluating the antidiabetic effect of LBP. Additionally, serum creatinine (sCr), blood urea nitrogen (BUN), and urine microalbumin were tested to evaluate the renal function. HE and PAS stainings were performed to evaluate the morphology and injury of the kidney. The results showed that LBP significantly reduces the glucose level and ameliorates the insulin resistance of diabetic mice. Importantly, LBP improves renal function by lowering the levels of sCr, BUN, and microalbumin in diabetic mice and relieves the injury in the renal glomeruli and tubules of the DN mice. Furthermore, LBP attenuates renal inflammation as evidenced by downregulating the mRNA levels of TNFα, IL1 β, IL6, and SAA3 in the renal cortex, as well as reducing the elevated circulating level and protein depositions of SAA3 in the kidney. In addition, our western blot results showed that NF-κB p65 nuclear translocation and the degradation of inhibitory κB-α (IκBα) occurred during the progress of inflammation, and such activated signaling was restrained by LBP. In conclusion, our findings suggest that LBP is a potential antidiabetic agent, which ameliorates the inflammation in DN through inhibiting NF-κB activation.http://dx.doi.org/10.1155/2022/7847135
spellingShingle Fengqi Wan
Fulin Ma
Jiaxin Wu
Xinyu Qiao
Minxue Chen
Wenjian Li
Liang Ma
Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
Analytical Cellular Pathology
title Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
title_full Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
title_fullStr Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
title_full_unstemmed Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
title_short Effect of Lycium barbarum Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-κB Activation in a Mouse Model of Diabetic Nephropathy
title_sort effect of lycium barbarum polysaccharide on decreasing serum amyloid a3 expression through inhibiting nf κb activation in a mouse model of diabetic nephropathy
url http://dx.doi.org/10.1155/2022/7847135
work_keys_str_mv AT fengqiwan effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT fulinma effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT jiaxinwu effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT xinyuqiao effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT minxuechen effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT wenjianli effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy
AT liangma effectoflyciumbarbarumpolysaccharideondecreasingserumamyloida3expressionthroughinhibitingnfkbactivationinamousemodelofdiabeticnephropathy